|Treatment||N||Relapsed Brain Tumor||Medium # Recurrences||mOS (months)||Survival Rate (%)|
|6 months||9 months||12 months|
|Ad + V (Overall)||17||16 GBM, 1 AA||3||12.8||87||65||54|
|Ad + V (20 mg)||7||6 GBM, 1 AA||3||12.8||100||86||71|
Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.
Doug Kass shares his thoughts on whether Judgment Day is here for the financials and discusses General Electric, Apple and Caterpillar.
Here's how to rake in the profits off some potential big breakouts.